Prolonging culture of primary human keratinocytes isolated from suction blisters with the Rho kinase inhibitor Y-27632

Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens

(2017) Xuefeng Liu et al.   Nature Protocols

Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation

(2016) Alessia Cavazza et al.   Stem Cell Reports

Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction

(2016) Naoki Okumura et al.   Scientific Reports

Dissecting the Calcium-Induced Differentiation of Human Primary Keratinocytes Stem Cells by Integrative and Structural Network Analyses

(2015) Kiana Toufighi et al.   PLoS Computational Biology

The effect of Rho kinase inhibition on long-term keratinocyte proliferation is rapid and conditional

(2014) Sandra Chapman et al.   Stem Cell Research & Therapy

Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism

(2013) Amy P. Hsu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Lung Parenchyma Surgery in Autosomal Dominant Hyper-IgE Syndrome

(2013) Alexandra F. Freeman et al.   JOURNAL OF CLINICAL IMMUNOLOGY

IL-17A and IFN-γ Synergistically Induce RNase 7 Expression via STAT3 in Primary Keratinocytes

(2013) Maren Simanski et al.   PLoS One

Capturing epidermal stemness for regenerative medicine

(2012) Yann Barrandon et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells

(2011) Xuefeng Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

Mucosal Immunity andCandida albicansInfection

(2011) David L. Moyes et al.   Clinical & Developmental Immunology

Update on the epidermal differentiation complex

(2011) Julie Henry   Frontiers in Bioscience-Landmark

Innate and adaptive immune responses against Staphylococcus aureus skin infections

(2011) Sheila Krishna et al.   Seminars in Immunopathology

Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor

(2010) Sandra Chapman et al.   JOURNAL OF CLINICAL INVESTIGATION